Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The worldwide Metabotropic Glutamate Receptor 5 market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 4.4% during the forecast period.
This report presents the market size and development trends by detailing the Metabotropic Glutamate Receptor 5 market revenue, market share and growth rate from 2015-2026, and it gives a thorough analysis by various product types, applications, regions, and main participants. The market conditions (2015-2019), corporate competition pattern, corporate SWOT analysis are elaborated, and other qualitative analyses like market dynamics, market penetration, market business environment analyses, the regional regulatory scenario in the Metabotropic Glutamate Receptor 5 market will be shown in this report. In short, this report will comprehensively reveal the characteristics of Metabotropic Glutamate Receptor 5 industry and will help you to build a panoramic view of the industrial development.
Metabotropic Glutamate Receptor 5 Market, By Type:
Alloswitch-1
BMS-952048
BMS-955829
Dipraglurant ER
Others
Metabotropic Glutamate Receptor 5 Market, By Application:
Major Depressive Disorder
Alcohol Assiction
Alzheimer's Disease
Others
Some of the leading players are as follows:
Novartis AG
Toray Industries Inc
Bristol-Myers Squibb Company
Richter Gedeon Nyrt
Merz Pharma GmbH & Co KgaA
Heptares Therapeutics Ltd
Eisai Co Ltd
Eli Lilly and Company
Sumitomo Dainippon Pharma Co Ltd
Johnson & Johnson
Aevi Genomic Medicine Inc
Addex Therapeutics Ltd
Geographically, Major regions are analyzed in details are as follows:
-
North America
-
Europe
-
Asia Pacific
-
Latin America
-
Middle East & Africa
Table of Contents
1 Methodology and Scope
-
1.1 Market Segmentation & Scope
-
1.1.1 Technology Type
-
1.1.2 Product
-
1.1.3 Application
-
1.1.4 Regional scope
-
1.1.5 Estimates and forecast timeline
-
1.2 Research Methodology
-
1.3 Information Procurement
-
1.3.1 Purchased database
-
1.3.2 Internal database
-
1.3.3 Secondary sources
-
1.3.4 Primary research
-
1.3.5 Details of primary research
-
1.4 Information or Data Analysis
-
1.4.1 Data analysis models
-
1.5 Market Formulation & Validation
-
1.6 Model Details
-
1.6.1 Commodity flow analysis
-
1.6.2 Volume price analysis
-
1.7 List of Secondary Sources
-
1.8 List of Abbreviations
2 Executive Summary
-
2.1 Market Outlook
-
2.2 Segment Outlook
3 Market Variables, Trends, & Scope
-
3.1 Market Lineage Outlook
-
3.1.1 Parent market outlook
-
3.1.2 Ancillary market outlook
-
3.2 Market Segmentation
-
3.2.1 Analysis
-
3.3 Market Dynamics
-
3.3.1 Market driver analysis
-
3.3.2 Market restraint analysis
-
3.3.3 Industry opportunities
-
3.4 Penetration & Growth Prospect Mapping
-
3.4.1 Penetration & growth prospect mapping analysis
-
3.5 Business Environment Analysis Tools
-
3.5.1 Porter's five forces analysis
-
3.5.2 PESTLE analysis
-
3.5.3 Major deals & strategic alliances analysis
4 Metabotropic Glutamate Receptor 5 Market: Technology Type Analysis
-
4.1 Metabotropic Glutamate Receptor 5 Technology Type Market Share Analysis, 2018 & 2026
-
4.2 Metabotropic Glutamate Receptor 5 Technology Type Market: Segment Dashboard
-
4.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Technology Type Segment
4.3.1 Alloswitch-1
4.3.2 BMS-952048
4.3.3 BMS-955829
4.3.4 Dipraglurant ER
4.3.5 Others
5 Metabotropic Glutamate Receptor 5 Market: Product Analysis
-
5.1 Metabotropic Glutamate Receptor 5 Product Market Share Analysis, 2018 & 2026
-
5.2 Metabotropic Glutamate Receptor 5 Product Market: Segment Dashboard
-
5.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Product Segment
6 Metabotropic Glutamate Receptor 5 Market: Application Analysis
-
6.1 Metabotropic Glutamate Receptor 5 Application Market Share Analysis, 2018 & 2026
-
6.2 Metabotropic Glutamate Receptor 5 Application Market: Segment Dashboard
-
6.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Application Segment
6.3.1 Major Depressive Disorder
6.3.2 Alcohol Assiction
6.3.3 Alzheimer's Disease
6.3.4 Others
7 Metabotropic Glutamate Receptor 5 Market: Regional Analysis
-
7.1 Metabotropic Glutamate Receptor 5 Regional Market Share Analysis, 2018 & 2026
-
7.2 Metabotropic Glutamate Receptor 5 Regional Market: Segment Dashboard
-
7.3 Regional Market Snapshot (Market Size, CAGR, Top Countries)
-
7.4 List of Players at Regional Level
-
7.4.1 North America
-
7.4.2 Europe
-
7.4.3 Asia Pacific
-
7.5 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)
-
7.5.1 North America
-
7.5.2 Europe
-
7.5.3 Asia Pacific
-
7.5.4 Latin America
-
7.5.5 MEA
-
7.6 Market Size & Forecasts, and Trend Analysis, 2015 to 2026
-
7.6.1 North America
-
7.6.2 Europe
-
7.6.3 Asia Pacific
-
7.6.4 Latin America
-
7.6.5 Middle East & Africa
8 Competitive Analysis
-
8.1 Recent Developments & Impact Analysis, by Key Market Participants
-
8.2 Strategic Framework/Competition Categorization (Key innovators, Market leaders, Emerging players)
-
8.3 Vendor Landscape
-
8.3.1 Company market position analysis (Geographic presence, service portfolio, strategic initiatives)
9 Company Profiles
9.1 Novartis AG
9.1.1 Novartis AG Company overview
9.1.2 Financial performance
9.1.3 Product benchmarking
9.1.4 Strategic initiatives
9.1.5 SWOT analysis
9.2 Toray Industries Inc
9.2.1 Toray Industries Inc Company overview
9.2.2 Financial performance
9.2.3 Product benchmarking
9.2.4 Strategic initiatives
9.2.5 SWOT analysis
9.3 Bristol-Myers Squibb Company
9.3.1 Bristol-Myers Squibb Company Company overview
9.3.2 Financial performance
9.3.3 Product benchmarking
9.3.4 Strategic initiatives
9.3.5 SWOT analysis
9.4 Richter Gedeon Nyrt
9.4.1 Richter Gedeon Nyrt Company overview
9.4.2 Financial performance
9.4.3 Product benchmarking
9.4.4 Strategic initiatives
9.4.5 SWOT analysis
9.5 Merz Pharma GmbH & Co KgaA
9.5.1 Merz Pharma GmbH & Co KgaA Company overview
9.5.2 Financial performance
9.5.3 Product benchmarking
9.5.4 Strategic initiatives
9.5.5 SWOT analysis
9.6 Heptares Therapeutics Ltd
9.6.1 Heptares Therapeutics Ltd Company overview
9.6.2 Financial performance
9.6.3 Product benchmarking
9.6.4 Strategic initiatives
9.6.5 SWOT analysis
9.7 Eisai Co Ltd
9.7.1 Eisai Co Ltd Company overview
9.7.2 Financial performance
9.7.3 Product benchmarking
9.7.4 Strategic initiatives
9.7.5 SWOT analysis
9.8 Eli Lilly and Company
9.8.1 Eli Lilly and Company Company overview
9.8.2 Financial performance
9.8.3 Product benchmarking
9.8.4 Strategic initiatives
9.8.5 SWOT analysis
9.9 Sumitomo Dainippon Pharma Co Ltd
9.9.1 Sumitomo Dainippon Pharma Co Ltd Company overview
9.9.2 Financial performance
9.9.3 Product benchmarking
9.9.4 Strategic initiatives
9.9.5 SWOT analysis
9.10 Johnson & Johnson
9.10.1 Johnson & Johnson Company overview
9.10.2 Financial performance
9.10.3 Product benchmarking
9.10.4 Strategic initiatives
9.10.5 SWOT analysis
9.11 Aevi Genomic Medicine Inc
9.11.1 Aevi Genomic Medicine Inc Company overview
9.11.2 Financial performance
9.11.3 Product benchmarking
9.11.4 Strategic initiatives
9.11.5 SWOT analysis
9.12 Addex Therapeutics Ltd
9.12.1 Addex Therapeutics Ltd Company overview
9.12.2 Financial performance
9.12.3 Product benchmarking
9.12.4 Strategic initiatives
9.12.5 SWOT analysis
The List of Tables and Figures (Totals 109 Figures and 156 Tables)
Figure Alloswitch-1 Metabotropic Glutamate Receptor 5 market, 2015 - 2026 (USD Million)
Figure BMS-952048 Metabotropic Glutamate Receptor 5 market, 2015 - 2026 (USD Million)
Figure BMS-955829 Metabotropic Glutamate Receptor 5 market, 2015 - 2026 (USD Million)
Figure Dipraglurant ER Metabotropic Glutamate Receptor 5 market, 2015 - 2026 (USD Million)
Figure Others Metabotropic Glutamate Receptor 5 market, 2015 - 2026 (USD Million)
Figure Major Depressive Disorder market, 2015 - 2026 (USD Million)
Figure Alcohol Assiction market, 2015 - 2026 (USD Million)
Figure Alzheimer's Disease market, 2015 - 2026 (USD Million)
Figure Others market, 2015 - 2026 (USD Million)
-
Table List of players in North America
-
Table List of players in Europe
-
Table List of players in Asia Pacific
-
Table SWOT analysis
-
Table North America Metabotropic Glutamate Receptor 5 market, by country, 2015 - 2026 (USD Million)
-
Table North America Metabotropic Glutamate Receptor 5 market, by type, 2015 - 2026 (USD Million)
-
Table North America Metabotropic Glutamate Receptor 5 market, by product, 2015 - 2026 (USD Million)
-
Table North America Metabotropic Glutamate Receptor 5 market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table U.S. Metabotropic Glutamate Receptor 5 market, by type, 2015 - 2026 (USD Million)
-
Table U.S. Metabotropic Glutamate Receptor 5 market, by product, 2015 - 2026 (USD Million)
-
Table U.S. Metabotropic Glutamate Receptor 5 market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Canada Metabotropic Glutamate Receptor 5 market, by type, 2015 - 2026 (USD Million)
-
Table Canada Metabotropic Glutamate Receptor 5 market, by product, 2015 - 2026 (USD Million)
-
Table Canada Metabotropic Glutamate Receptor 5 market, by application, 2015 - 2026 (USD Million)
-
Table Europe Metabotropic Glutamate Receptor 5 market, by country, 2015 - 2026 (USD Million)
-
Table Europe Metabotropic Glutamate Receptor 5 market, by type, 2015 - 2026 (USD Million)
-
Table Europe Metabotropic Glutamate Receptor 5 market, by product, 2015 - 2026 (USD Million)
-
Table Europe Metabotropic Glutamate Receptor 5 market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table U.K. Metabotropic Glutamate Receptor 5 market, by type, 2015 - 2026 (USD Million)
-
Table U.K. Metabotropic Glutamate Receptor 5 market, by product, 2015 - 2026 (USD Million)
-
Table U.K. Metabotropic Glutamate Receptor 5 market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Germany Metabotropic Glutamate Receptor 5 market, by type, 2015 - 2026 (USD Million)
-
Table Germany Metabotropic Glutamate Receptor 5 market, by product, 2015 - 2026 (USD Million)
-
Table Germany Metabotropic Glutamate Receptor 5 market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table France Metabotropic Glutamate Receptor 5 market, by type, 2015 - 2026 (USD Million)
-
Table France Metabotropic Glutamate Receptor 5 market, by product, 2015 - 2026 (USD Million)
-
Table France Metabotropic Glutamate Receptor 5 market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Italy Metabotropic Glutamate Receptor 5 market, by type, 2015 - 2026 (USD Million)
-
Table Italy Metabotropic Glutamate Receptor 5 market, by product, 2015 - 2026 (USD Million)
-
Table Italy Metabotropic Glutamate Receptor 5 market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Spain Metabotropic Glutamate Receptor 5 market, by type, 2015 - 2026 (USD Million)
-
Table Spain Metabotropic Glutamate Receptor 5 market, by product, 2015 - 2026 (USD Million)
-
Table Spain Metabotropic Glutamate Receptor 5 market, by application, 2015 - 2026 (USD Million)
-
Table Asia Pacific Metabotropic Glutamate Receptor 5 market, by country, 2015 - 2026 (USD Million)
-
Table Asia Pacific Metabotropic Glutamate Receptor 5 market, by type, 2015 - 2026 (USD Million)
-
Table Asia Pacific Metabotropic Glutamate Receptor 5 market, by product, 2015 - 2026 (USD Million)
-
Table Asia Pacific Metabotropic Glutamate Receptor 5 market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table China Metabotropic Glutamate Receptor 5 market, by type, 2015 - 2026 (USD Million)
-
Table China Metabotropic Glutamate Receptor 5 market, by product, 2015 - 2026 (USD Million)
-
Table China Metabotropic Glutamate Receptor 5 market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Japan Metabotropic Glutamate Receptor 5 market, by type, 2015 - 2026 (USD Million)
-
Table Japan Metabotropic Glutamate Receptor 5 market, by product, 2015 - 2026 (USD Million)
-
Table Japan Metabotropic Glutamate Receptor 5 market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table India Metabotropic Glutamate Receptor 5 market, by type, 2015 - 2026 (USD Million)
-
Table India Metabotropic Glutamate Receptor 5 market, by product, 2015 - 2026 (USD Million)
-
Table India Metabotropic Glutamate Receptor 5 market, by application, 2015 - 2026 (USD Million)
-
Table Latin America Metabotropic Glutamate Receptor 5 market, by country, 2015 - 2026 (USD Million)
-
Table Latin America Metabotropic Glutamate Receptor 5 market, by type, 2015 - 2026 (USD Million)
-
Table Latin America Metabotropic Glutamate Receptor 5 market, by product, 2015 - 2026 (USD Million)
-
Table Latin America Metabotropic Glutamate Receptor 5 market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Brazil Metabotropic Glutamate Receptor 5 market, by type, 2015 - 2026 (USD Million)
-
Table Brazil Metabotropic Glutamate Receptor 5 market, by product, 2015 - 2026 (USD Million)
-
Table Brazil Metabotropic Glutamate Receptor 5 market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Mexico Metabotropic Glutamate Receptor 5 market, by type, 2015 - 2026 (USD Million)
-
Table Mexico Metabotropic Glutamate Receptor 5 market, by product, 2015 - 2026 (USD Million)
-
Table Mexico Metabotropic Glutamate Receptor 5 market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Argentina Metabotropic Glutamate Receptor 5 market, by type, 2015 - 2026 (USD Million)
-
Table Argentina Metabotropic Glutamate Receptor 5 market, by product, 2015 - 2026 (USD Million)
-
Table Argentina Metabotropic Glutamate Receptor 5 market, by application, 2015 - 2026 (USD Million)
-
Table MEA Metabotropic Glutamate Receptor 5 market, by country, 2015 - 2026 (USD Million)
-
Table MEA Metabotropic Glutamate Receptor 5 market, by type, 2015 - 2026 (USD Million)
-
Table MEA Metabotropic Glutamate Receptor 5 market, by product, 2015 - 2026 (USD Million)
-
Table MEA Metabotropic Glutamate Receptor 5 market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table South Africa Metabotropic Glutamate Receptor 5 market, by type, 2015 - 2026 (USD Million)
-
Table South Africa Metabotropic Glutamate Receptor 5 market, by product, 2015 - 2026 (USD Million)
-
Table South Africa Metabotropic Glutamate Receptor 5 market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Nigeria Metabotropic Glutamate Receptor 5 market, by type, 2015 - 2026 (USD Million)
-
Table Nigeria Metabotropic Glutamate Receptor 5 market, by product, 2015 - 2026 (USD Million)
-
Table Nigeria Metabotropic Glutamate Receptor 5 market, by application, 2015 - 2026 (USD Million)
-
Table Recent Developments & Impact Analysis, by Key Market Participants
-
Table Recent Developments & Impact Analysis, by Key Market Participants
-
Table Company market position analysis
Table Company Profiles
Table Novartis AG Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Toray Industries Inc Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Bristol-Myers Squibb Company Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Richter Gedeon Nyrt Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Merz Pharma GmbH & Co KgaA Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Heptares Therapeutics Ltd Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Eisai Co Ltd Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Eli Lilly and Company Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Sumitomo Dainippon Pharma Co Ltd Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Johnson & Johnson Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Aevi Genomic Medicine Inc Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Addex Therapeutics Ltd Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
-
